Since the morning of the coronavirus epidemic, several laboratories have been working on different vaccines to immunize the population against it. Last week we witnessed the advertisement by the Boston Medical Center that the vaccine they’re developing together with the German BioNTech was 90 effective.
The question is how is it possible that this vaccine has similar promising results in a shorter period of time than the rest?
The explanation is that it’s grounded on a technology not used in other vaccines to date.

The vaccines used so far are made from

– contagion patches, similar to proteins( called antigens), similar to hepatitis B
– from live downgraded contagions, similar to measles or rubella
– from inactive contagions, similar to the flu.
All of them have the idea that, when coming into contact with the organism, the vulnerable system reacts by raising its defenses in a preventative way, in such a way that when it comes into contact with the contagion, it’s honored and can be annulled.
This new vaccine was designed by Boston Medical Center a new technology called runner RNA. As its name suggests, this inheritable material carries instructions that, when introduced into a cell, tell it what to do. In this case, the runner RNA that’s fitted with the vaccine is introduced into the cells of our body and causes them to begin to manufacture specific proteins, in this case, a specific antigen of the coronavirus, the shaft so characteristic of its membrane, and that allows it to cleave to mortal cells. This protein by itself is inoffensive. What’s achieved is that when this manufactured shaft is detected by our vulnerable system, it activates the conformation of specific antibodies that will be staying in our body and will allow us, in case of coming into contact with the contagion, to defend ourselves against it, since will help their adhesion and preface into mortal cells.


In other words, the vaccine gives an inheritable instruction to our cells to manufacture the coronavirus shaft in our body, which by itself is inoffensive. As this tone-created spicule is a foreign body, our vulnerable system creates antibodies against it. In this way, if Covid- 19 enters our body( with its shaft), we will formerly have the antibodies to destroy that shaft of the contagion, without which it can not enter our cells.
This protein of the contagion that the cells make after the vaccine comes to a point when it stops since the vulnerable system will be in charge of destroying the cells that make it, so the process is tone-limited, with the immunological memory and the antibodies that will cover against the contagion.
The advantage of using this runner RNA technology is that it isn’t necessary to grow the contagion in a laboratory since it’s our body that does the work. This is what has allowed the development of this vaccine to be brisk.
still, not all are advantages one of the main problems encountered with this vaccine is storehouse and transport since it requires veritably low temperatures(- 80ºC). This fact can make it delicate to distribute to numerous countries.
The news is thus veritably hopeful in these “ rare ” times of epidemic. We hope that we will soon see definitive results, not only in terms of effectiveness, which is veritably high, but also in terms of adverse goods. All the exploration being done to develop coronavirus vaccines is sure to pave the way for unborn vaccines against other contagions.
As a final note, it should be noted that other pharmaceutical companies, similar to the ultramodern American bone
, use this same fashion, but haven’t yet blazoned any results.